Αthanasios Fassas
Αthanasios Fassas publishes mostly in Hematology, Pathology and Forensic Medicine and Genetics, on topics such as Chronic Lymphocytic Leukemia Research, Hematopoietic Stem Cell Transplantation and Lymphoma Diagnosis and Treatment.
- World rank
- #740,685 of 7,710,434 ranked researchers
- Rank in Greece
- #2,773 of 33,280
- Works
- 122
- Citations
- 7.3k
- Citations per work
- 59.5
What does Αthanasios Fassas research?
Αthanasios Fassas's work is mostly in Medicine (59%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7259.3%
- Medicine7259.3%
- Everything else3327.3%
- Life Sciences1613.4%
- 1Hematology21% of their works
- 2Pathology and Forensic Medicine18% of their works
- 3Genetics14% of their works
- 4Immunology7% of their works
- 5Oncology6% of their works
- 6Molecular Biology6% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Lymphoma Diagnosis and Treatment
- Multiple Sclerosis Research Studies
- Systemic Sclerosis and Related Diseases
- Polyomavirus and related diseases
- Monoclonal and Polyclonal Antibodies Research
- Immunodeficiency and Autoimmune Disorders
Which keywords describe Αthanasios Fassas's research?
The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Bone Marrow Niche, Hematopoietic Stem Cells, Classification, Lymphoma and Diagnostic Criteria.
- Genetic Mutations
- Polyomavirus
- Fc Receptors
- Fibrosis
- Diagnostic Criteria
- Classification
- Bone Marrow Niche
- Chronic Lymphocytic Leukemia
- Rituximab
- Genomic Aberrations
- Hematopoietic Stem Cells
- Lymphoma
- Multiple Sclerosis
- Systemic Sclerosis
- Merkel Cell Carcinoma
- Therapeutic Antibodies
- Primary Immunodeficiency
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Rituximab572 topics
- Chronic Lymphocytic Leukemia351 topic
- Genomic Aberrations351 topic
- Bone Marrow Niche261 topic
- Hematopoietic Stem Cells261 topic
- Classification221 topic
- Lymphoma221 topic
- Diagnostic Criteria211 topic
- Multiple Sclerosis211 topic
- Fibrosis151 topic
- Systemic Sclerosis151 topic
- Fc Receptors141 topic
- Merkel Cell Carcinoma141 topic
- Polyomavirus141 topic
- Therapeutic Antibodies141 topic
- Genetic Mutations131 topic
- Primary Immunodeficiency131 topic
Where does Αthanasios Fassas work?
Αthanasios Fassas's main affiliation in the publication record is G. Papanikolaou General Hospital, Greece.
How many publications and citations does Αthanasios Fassas have?
OpenAlex counts 122 works and 7,263 citations for Αthanasios Fassas, an h-index of 39, ranking #740,685 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Αthanasios Fassas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.